IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v15y2024i1d10.1038_s41467-024-45548-w.html
   My bibliography  Save this article

The transcription factor ChREBP Orchestrates liver carcinogenesis by coordinating the PI3K/AKT signaling and cancer metabolism

Author

Listed:
  • Emmanuel Benichou

    (Université Paris Cité, Institut Cochin, INSERM, CNRS)

  • Bolaji Seffou

    (Université Paris Cité, Institut Cochin, INSERM, CNRS)

  • Selin Topçu

    (Université Paris Cité, Institut Cochin, INSERM, CNRS)

  • Ophélie Renoult

    (Nantes Université, INSERM U1307, CNRS 6075)

  • Véronique Lenoir

    (Université Paris Cité, Institut Cochin, INSERM, CNRS)

  • Julien Planchais

    (Université Paris Cité, Institut Cochin, INSERM, CNRS)

  • Caroline Bonner

    (Institut Pasteur de Lille
    INSERM
    European Genomic Institute for Diabetes
    Université de Lille)

  • Catherine Postic

    (Université Paris Cité, Institut Cochin, INSERM, CNRS)

  • Carina Prip-Buus

    (Université Paris Cité, Institut Cochin, INSERM, CNRS)

  • Claire Pecqueur

    (Nantes Université, INSERM U1307, CNRS 6075)

  • Sandra Guilmeau

    (Université Paris Cité, Institut Cochin, INSERM, CNRS)

  • Marie-Clotilde Alves-Guerra

    (Université Paris Cité, Institut Cochin, INSERM, CNRS)

  • Renaud Dentin

    (Université Paris Cité, Institut Cochin, INSERM, CNRS
    Institut Cochin, Faculté de Médecine 3ème étage)

Abstract

Cancer cells integrate multiple biosynthetic demands to drive unrestricted proliferation. How these cellular processes crosstalk to fuel cancer cell growth is still not fully understood. Here, we uncover the mechanisms by which the transcription factor Carbohydrate responsive element binding protein (ChREBP) functions as an oncogene during hepatocellular carcinoma (HCC) development. Mechanistically, ChREBP triggers the expression of the PI3K regulatory subunit p85α, to sustain the activity of the pro-oncogenic PI3K/AKT signaling pathway in HCC. In parallel, increased ChREBP activity reroutes glucose and glutamine metabolic fluxes into fatty acid and nucleic acid synthesis to support PI3K/AKT-mediated HCC growth. Thus, HCC cells have a ChREBP-driven circuitry that ensures balanced coordination between PI3K/AKT signaling and appropriate cell anabolism to support HCC development. Finally, pharmacological inhibition of ChREBP by SBI-993 significantly suppresses in vivo HCC tumor growth. Overall, we show that targeting ChREBP with specific inhibitors provides an attractive therapeutic window for HCC treatment.

Suggested Citation

  • Emmanuel Benichou & Bolaji Seffou & Selin Topçu & Ophélie Renoult & Véronique Lenoir & Julien Planchais & Caroline Bonner & Catherine Postic & Carina Prip-Buus & Claire Pecqueur & Sandra Guilmeau & Ma, 2024. "The transcription factor ChREBP Orchestrates liver carcinogenesis by coordinating the PI3K/AKT signaling and cancer metabolism," Nature Communications, Nature, vol. 15(1), pages 1-29, December.
    • Handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-45548-w
    DOI: 10.1038/s41467-024-45548-w
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-024-45548-w
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-024-45548-w?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Dannielle DeWaal & Veronique Nogueira & Alexander R. Terry & Krushna C. Patra & Sang-Min Jeon & Grace Guzman & Jennifer Au & Christopher P. Long & Maciek R. Antoniewicz & Nissim Hay, 2018. "Author Correction: Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin," Nature Communications, Nature, vol. 9(1), pages 1-1, December.
    2. Quentin Bayard & Léa Meunier & Camille Peneau & Victor Renault & Jayendra Shinde & Jean-Charles Nault & Iadh Mami & Gabrielle Couchy & Giuliana Amaddeo & Emmanuel Tubacher & Delphine Bacq & Vincent Me, 2018. "Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress," Nature Communications, Nature, vol. 9(1), pages 1-14, December.
    3. Richard Possemato & Kevin M. Marks & Yoav D. Shaul & Michael E. Pacold & Dohoon Kim & Kıvanç Birsoy & Shalini Sethumadhavan & Hin-Koon Woo & Hyun G. Jang & Abhishek K. Jha & Walter W. Chen & Francesca, 2011. "Functional genomics reveal that the serine synthesis pathway is essential in breast cancer," Nature, Nature, vol. 476(7360), pages 346-350, August.
    4. Ji Hoon Kim & Bo Hwa Sohn & Hyun-Sung Lee & Sang-Bae Kim & Jeong Eun Yoo & Yun-Yong Park & Woojin Jeong & Sung Sook Lee & Eun Sung Park & Ahmed Kaseb & Baek Hui Kim & Wan Bae Kim & Jong Eun Yeon & Kwa, 2014. "Genomic Predictors for Recurrence Patterns of Hepatocellular Carcinoma: Model Derivation and Validation," PLOS Medicine, Public Library of Science, vol. 11(12), pages 1-16, December.
    5. Dannielle DeWaal & Veronique Nogueira & Alexander R. Terry & Krushna C. Patra & Sang-Min Jeon & Grace Guzman & Jennifer Au & Christopher P. Long & Maciek R. Antoniewicz & Nissim Hay, 2018. "Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin," Nature Communications, Nature, vol. 9(1), pages 1-14, December.
    6. Eline Sijbesma & Emira Visser & Kathrin Plitzko & Philipp Thiel & Lech-Gustav Milroy & Markus Kaiser & Luc Brunsveld & Christian Ottmann, 2020. "Structure-based evolution of a promiscuous inhibitor to a selective stabilizer of protein–protein interactions," Nature Communications, Nature, vol. 11(1), pages 1-9, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Kuei-Pin Chung & Chih-Ning Cheng & Yi-Jung Chen & Chia-Lang Hsu & Yen-Lin Huang & Min-Shu Hsieh & Han-Chun Kuo & Ya-Ting Lin & Yi-Hsiu Juan & Kiichi Nakahira & Yen-Fu Chen & Wei-Lun Liu & Sheng-Yuan R, 2024. "Alveolar epithelial cells mitigate neutrophilic inflammation in lung injury through regulating mitochondrial fatty acid oxidation," Nature Communications, Nature, vol. 15(1), pages 1-23, December.
    2. Tuncer, Turker & Ertam, Fatih, 2020. "Neighborhood component analysis and reliefF based survival recognition methods for Hepatocellular carcinoma," Physica A: Statistical Mechanics and its Applications, Elsevier, vol. 540(C).
    3. Catherine S. Blaha & Gopalakrishnan Ramakrishnan & Sang-Min Jeon & Veronique Nogueira & Hyunsoo Rho & Soeun Kang & Prashanth Bhaskar & Alexander R. Terry & Alexandre F. Aissa & Maxim V. Frolov & Krush, 2022. "A non-catalytic scaffolding activity of hexokinase 2 contributes to EMT and metastasis," Nature Communications, Nature, vol. 13(1), pages 1-20, December.
    4. Camilla Tombari & Alessandro Zannini & Rebecca Bertolio & Silvia Pedretti & Matteo Audano & Luca Triboli & Valeria Cancila & Davide Vacca & Manuel Caputo & Sara Donzelli & Ilenia Segatto & Simone Vodr, 2023. "Mutant p53 sustains serine-glycine synthesis and essential amino acids intake promoting breast cancer growth," Nature Communications, Nature, vol. 14(1), pages 1-21, December.
    5. Tom Nyen & Mélanie Planque & Lilian Wagensveld & Joao A. G. Duarte & Esther A. Zaal & Ali Talebi & Matteo Rossi & Pierre-René Körner & Lara Rizzotto & Stijn Moens & Wout Wispelaere & Regina E. M. Baid, 2022. "Serine metabolism remodeling after platinum-based chemotherapy identifies vulnerabilities in a subgroup of resistant ovarian cancers," Nature Communications, Nature, vol. 13(1), pages 1-19, December.
    6. Kui Wang & Li Luo & Shuyue Fu & Mao Wang & Zihao Wang & Lixia Dong & Xingyun Wu & Lunzhi Dai & Yong Peng & Guobo Shen & Hai-Ning Chen & Edouard Collins Nice & Xiawei Wei & Canhua Huang, 2023. "PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    7. Eirini Lionaki & Ilias Gkikas & Ioanna Daskalaki & Maria-Konstantina Ioannidi & Maria I. Klapa & Nektarios Tavernarakis, 2022. "Mitochondrial protein import determines lifespan through metabolic reprogramming and de novo serine biosynthesis," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    8. Seong Eun Lee & Seongyeol Park & Shinae Yi & Na Rae Choi & Mi Ae Lim & Jae Won Chang & Ho-Ryun Won & Je Ryong Kim & Hye Mi Ko & Eun-Jae Chung & Young Joo Park & Sun Wook Cho & Hyeong Won Yu & June You, 2024. "Unraveling the role of the mitochondrial one-carbon pathway in undifferentiated thyroid cancer by multi-omics analyses," Nature Communications, Nature, vol. 15(1), pages 1-17, December.
    9. Gabrielle Manteaux & Alix Amsel & Blanche Riquier-Morcant & Jaime Prieto Romero & Laurie Gayte & Benjamin Fourneaux & Marion Larroque & Nadège Gruel & Chloé Quignot & Gaelle Perot & Solenn Jacq & Madi, 2024. "A metabolic crosstalk between liposarcoma and muscle sustains tumor growth," Nature Communications, Nature, vol. 15(1), pages 1-15, December.
    10. Nicole Kiweler & Catherine Delbrouck & Vitaly I. Pozdeev & Laura Neises & Leticia Soriano-Baguet & Kim Eiden & Feng Xian & Mohaned Benzarti & Lara Haase & Eric Koncina & Maryse Schmoetten & Christian , 2022. "Mitochondria preserve an autarkic one-carbon cycle to confer growth-independent cancer cell migration and metastasis," Nature Communications, Nature, vol. 13(1), pages 1-17, December.
    11. Marc Hennequart & Christiaan F. Labuschagne & Mylène Tajan & Steven E. Pilley & Eric C. Cheung & Nathalie M. Legrave & Paul C. Driscoll & Karen H. Vousden, 2021. "The impact of physiological metabolite levels on serine uptake, synthesis and utilization in cancer cells," Nature Communications, Nature, vol. 12(1), pages 1-10, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-45548-w. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.